What is the recommended Individual Thromboembolism Ratio (TTR) to maximize efficacy and safety when using Vitamin K Antagonists (VKAs)?
Clinical guidelines on the management of Atrial Fibrillation (AF) advocate an individual TTR of at least 65% to maximize efficacy and safety, and this should be the treatment target, although in clinical practice this may be more difficult to achieve.